INSERM (Institut National de la Santé et de la Recherche Médicale);Université Paris Diderot - Paris 7;Centre National de la Recherche Scientifique (C.N.R.S.);Universita Di Perugia;American University
发明人:
申请号：
EP14824852.9
公开号：
EP3089743B1
申请日:
2014.12.30
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention relates to methods and pharmaceutical compositions for the treatment of acute myeloid leukemia. In particular, the present invention relates to a method for treating NPM-1-driven acute myeloid leukemia (AML) in a subject in need thereof comprising administering the subject with a therapeutically effective amount of at least one arsenic compound and with a therapeutically effective amount of at least one retinoid.
